| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/03/2000 | CA2360671A1 P53 inhibitors and therapeutic use of the same |
| 08/03/2000 | CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers |
| 08/03/2000 | CA2359994A1 Production of tetravalent antibodies |
| 08/03/2000 | CA2357735A1 Modulation of immune response by ribavirin |
| 08/03/2000 | CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2356481A1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2356345A1 Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors |
| 08/03/2000 | CA2356313A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors |
| 08/03/2000 | CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 08/03/2000 | CA2325887A1 Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (hode) or the esters thereof from a mixture containing linoleic acid or the esters thereof |
| 08/02/2000 | EP1023903A1 Use of life attenuated bacteria for the manufacture of a submucosal vaccine |
| 08/02/2000 | EP1023897A2 Dermal agent |
| 08/02/2000 | EP1023894A1 Cosmetic composition comprising at least a compound containing a phenyloxime fragment |
| 08/02/2000 | EP1023889A1 A hair lotion for preventing hair loss comprising extracts of hop, rosemary and Swertia, further containing silanodiol salicylate |
| 08/02/2000 | EP1023445A1 Cadherin derived growth factor and the application thereof |
| 08/02/2000 | EP1023285A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 08/02/2000 | EP1023268A1 Isoquinolines as urokinase inhibitors |
| 08/02/2000 | EP1023263A1 Novel vitamin d analogues |
| 08/02/2000 | EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 08/02/2000 | EP1023080A1 Ligand binding site of rage and uses thereof |
| 08/02/2000 | EP1023066A1 Novel pyrazole and pyrazoline substituted compounds |
| 08/02/2000 | EP1023063A1 INDENO 1,2-c]-, NAPHTHO 1,2-c]- AND BENZO 6,7]CYCLOHEPTA 1,2-c]PYRAZOLE DERIVATIVES |
| 08/02/2000 | EP1023042A1 Personal cleansing compositions comprising mid-chain branched surfactants |
| 08/02/2000 | EP1023034A1 Cosmetic formulations for the prevention and therapy of hair loss |
| 08/02/2000 | CN1261887A Azetidinyl propylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 08/02/2000 | CN1261881A 6-azauracil derivatives as IL-5 inhibitors |
| 08/02/2000 | CN1261877A 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors |
| 08/02/2000 | CN1261803A Antioxidant enhancement of therapy for hyperproliferative conditions |
| 08/02/2000 | CN1261795A Compounds and methods |
| 08/02/2000 | CN1261538A External medicine with anti-infections and recovery function |
| 08/02/2000 | CN1261528A Beauty and skin composition containing plant extract |
| 08/02/2000 | CN1055089C Intermediate of protein kinase C inhibitor and its preparation |
| 08/02/2000 | CN1054993C Hair-growth, beauty-care and health-care medicinal liquor and method for preparing same |
| 08/01/2000 | US6096787 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 08/01/2000 | US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding |
| 08/01/2000 | US6096766 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 08/01/2000 | US6096753 Substituted pyrimidinone and pyridone compounds and methods of use |
| 08/01/2000 | US6096749 Pyrrolopyrimidine derivatives having pharmacological activity |
| 08/01/2000 | US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases |
| 08/01/2000 | US6096709 Use of angiotensin II fragments and analogs thereof in tissue repair |
| 08/01/2000 | US6096697 Personal cleansing compositions providing improved hair and skin conditioning |
| 08/01/2000 | US6096326 Skin care compositions and use |
| 08/01/2000 | US6096323 Vaccine against papillomatous digital dermatitis (PDD) |
| 08/01/2000 | US6096295 Composition for causing skin lightening |
| 08/01/2000 | CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 08/01/2000 | CA2151618C Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines |
| 07/29/2000 | CA2260397A1 Method of converting rendered triglyceride oil from marine sources into bland, stable food oil |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043419A2 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | WO2000043417A1 Use of peptides as cosmetics or pharmaceuticals for the regulation of immunological dysfunctions and in cutaneous inflammation |
| 07/27/2000 | WO2000043413A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043393A1 Novel angiogenesis inhibitors |
| 07/27/2000 | WO2000043387A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them |
| 07/27/2000 | WO2000043384A1 Aromatic heterocyclic compounds as antiinflammatory agents |
| 07/27/2000 | WO2000043373A2 Kinase inhibitors |
| 07/27/2000 | WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery |
| 07/27/2000 | WO2000043021A1 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 07/27/2000 | WO2000043020A1 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/27/2000 | WO2000043019A2 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/27/2000 | WO2000043008A1 Anti-androgens and methods for treating disease |
| 07/27/2000 | WO2000043001A1 Anti-inflammatory agents |
| 07/27/2000 | WO2000042990A1 Liposome formulations |
| 07/27/2000 | WO2000042852A1 Compounds and methods |
| 07/27/2000 | WO2000025724A3 COMPOSITIONS COMPRISING OLEUM $i(MELALEUCA) |
| 07/27/2000 | WO2000023068A3 Fumaric acid microtablets |
| 07/27/2000 | WO2000018358A3 Method of treating hair loss using ketoamides |
| 07/27/2000 | WO2000011171A3 Human rna-associated proteins |
| 07/27/2000 | WO2000008202A9 3-methylidenyl-2-indolinone modulators of protein kinase |
| 07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
| 07/27/2000 | WO1999062881A8 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2359680A1 Kinase inhibitors |
| 07/27/2000 | CA2359145A1 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359112A1 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2359107A1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them |
| 07/27/2000 | CA2358584A1 Method of enhancing needleless transdermal powdered drug delivery |
| 07/27/2000 | CA2358474A1 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 07/27/2000 | CA2358093A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | CA2356349A1 Novel angiogenesis inhibitors |
| 07/27/2000 | CA2355168A1 Egg anti-inflammatory composition and method of treating and preventing inflammation |
| 07/26/2000 | EP1021549A2 SENSE mRNA THERAPY |
| 07/26/2000 | EP1021193A1 THERAPEUTICALLY EFFECTIVE 1$g(a), 25-DIHYDROXYVITAMIN D 3? ANALOGS |
| 07/26/2000 | EP1021190A1 Novel amide derivatives |
| 07/26/2000 | EP1021182A1 Indeno[1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activity |
| 07/26/2000 | EP1021181A1 Carboxylic acid indole inhibitors of chemokines |
| 07/26/2000 | EP1021179A1 Method of enhancing hair growth |
| 07/26/2000 | EP1021177A1 Compositions and methods for prevention and treatment of vascular degenerative diseases |
| 07/26/2000 | EP1021161A1 Use of ellagic acid and its derivatives in cosmetics and dermatology |
| 07/26/2000 | EP1021159A1 Photoresponsive sunscreen compositions |
| 07/26/2000 | CN1261358A Angiogenesis inhiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 07/26/2000 | CN1261354A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261353A Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p561ck tyrosine kinases |
| 07/26/2000 | CN1261277A Novel substituted imidazole compounds |
| 07/26/2000 | CN1261274A Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them. |
| 07/26/2000 | CN1260994A Beaver fat preparation for treating scald |
| 07/26/2000 | CN1260979A Flexible massage pills |